UT Health San Antonio awarded $1.8 million NIH grant for research in addiction recovery support services
December 13, 2022
Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO, Dec. 13, 2022 – With the U.S. grappling with an unprecedented opioid-related overdose crisis, The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has be …
Tell your employee story on Comparably
December 12, 2022
To help promote career opportunities to potential employees, we are partnering with an organization called Comparably. We are seeking your help by asking you to take a confidential and quick three-minute survey to share your voice and help us tell our story in the market.
Mesa departing March 2023
December 12, 2022
Ruben Mesa, MD, FACP, executive director of the Mays Cancer Center at UT Health San Antonio since August 2017, will join Wake Forest University in Winston-Salem, NC, in March 2023.
Master of Physician Assistant Studies Class of 2022 graduates
December 12, 2022
The 41 members of the Master of Physician Assistant Studies Class of 2022 graduated on Dec. 9 at the Holly Auditorium.
National Academy of Inventors to induct Jean Jiang, PhD, of UT Health
December 12, 2022
Studies of cell channels lead to therapeutic antibodies in clinical trials From left, Yuting Lee, PhD; Jean Jiang, PhD; and Rui Hua, PhD, are pictured in the Jiang laboratory at the South Texas Research Facility. Jiang will be inducted as a Fellow of t …
San Antonio Current: Olympic gold medalist Brittney Griner arrives in San Antonio after 10 months in Russian custody
December 12, 2022
Ralph Riviello, MD, MS, FACEP, chair of Department of Emergency Medicine, was included in this story via a link to his interview with KSAT. Read More
MSN: Brittney Griner undergoing prisoner reintegration program in Texas
December 12, 2022
Ralph Riviello, MD, MS, FACEP, chair of Department of Emergency Medicine, was quoted in this story. Read More
New York Post: Brittney Griner undergoing prisoner reintegration program in Texas
December 12, 2022
Ralph Riviello, MD, MS, FACEP, chair of Department of Emergency Medicine, was quoted in this story. Read More
Precision Oncology News: Breast Cancer Patients Fare Better on Elacestrant With Longer CDK4/6 Inhibitor Treatment
December 12, 2022
Virginia Kaklamani, MD, Medical Oncology, was quoted in this story. Read More
The ACSO Post: Elacestrant vs Endocrine Monotherapy in Advanced Breast Cancer: Phase III EMERALD Trial
December 12, 2022
Virginia Kaklamani, MD, Medical Oncology, was quoted in this story. Read More